Suchergebnisse - "Qian, Hai"

PubPharm (864)

81

Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives

enthalten in: Military medical research | 2022

von Guo, Q. | Dai, X. | Yin, M. | +5

82

Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives

enthalten in: Military medical research | 2022

von Guo, Q. | Dai, X. | Yin, M. | +5

83

Recent advances in poly(ionic liquid)s for biomedical application

enthalten in: Biomaterials science | 2022

von Liu, C. | Raza, F. | Qian, H. | +1

84

Secretory type II cGMP-dependent protein kinase blocks activation of PDGFRβ via Ser254 in gastric cancer cells

enthalten in: Cell biology international | 2022

von Pang, J. | Li, G. | Qian, H. | +2

85

NEW BENZODIAZEPINE COMPOUNDS, AND PREPARATION METHOD THEREFOR AND USE THEREOF

enthalten in: Europäisches Patentamt | 2022

von QIAN HAI | SHI WEI | HUANG WENLONG | +6

86

NEW BENZODIAZEPINE COMPOUNDS, AND PREPARATION METHOD THEREFOR AND USE THEREOF

enthalten in: Europäisches Patentamt | 2022

von QIAN HAI | SHI WEI | HUANG WENLONG | +6

87

Benzodinitrogen medicine for sedation and hypnosis as well as preparation method and application of benzodinitrogen medicine

enthalten in: Europäisches Patentamt | 2022

von QIAN HAI | SHI WEI | HUANG WENLONG | +6

88

Corrigendum] Type II cGMP‑dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells

enthalten in: Molecular medicine reports | 2022

von Wu, M. | Wu, Y. | Qian, H. | +4

ErratumFor: Mol Med Rep. 2017 Oct;16(4):5729-5737. - PMID 28849123

89

Structure-based discovery of receptor tyrosine kinase AXL degraders with excellent anti-tumor activity by selectively degrading AXL and inducing methuosis

enthalten in: European journal of medicinal chemistry | 2022

von Shi, W. | Feng, Z. | Chi, F. | +8

90

Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment

enthalten in: Journal of medicinal chemistry | 2022

von Li, D. | Tu, Y. | Jin, K. | +13